Bud Genius Adds Leading Cannabis Marketing Pro to Lead Company Communications Programs
Randall A. Huft has worked with premier cannabis companies as a principal architect of growth strategies and positioning
Bud Genius, Inc. (www.bgmedtech.com) (OTC: RIGH), a leading laboratory for cannabis testing and profiling, developer of data-driven rating systems for marijuana strains, brand and retail development specialist, and licensee of celebrity-endorsed marijuana and hemp related merchandise, announced today they have added Randall A. Huft, noted cannabis marketing and communications expert, to their Executive Team.
Huft is well known in the legal cannabis industry and helped develop communications strategies and programs that have vaulted many companies into prominence. He was a consultant to Medbox during their meteoric rise and helped position the company as one of the leading stories of the year.
Huft also has a wealth of experience outside of the cannabis industry, and has worked with Fortune 500 companies, including United Airlines, Avis Car Rental, American Express, Hyundai, Walgreen’s, Gateway Computers, Loews Hotels, and AT&T.
“We are pleased to have Randall join our Executive Team and look forward to his many contributions,” said Angel Stanz, company CEO. “He shares my vision that moving forward with our 2015 Growth Initiatives it is vital that we have the best possible marketing, communications and messaging to keep our various audiences and investors informed, energized and engaged.”
For more information on Bud Genius, call (855) 723-3283, or visit BGMedtech.com
About Bud Genius:
An early leader in the cannabis industry, Bud Genius is one of the first established analytical cannabis laboratories in the United States. Bud Genius launched to bring vendors together with doctors, patients, and dispensaries that require certified products held to demanding standards. Bud Genius’ mission is to expand across the US and abroad, serving as the beacon of quality for medical cannabis and adult-use marijuana through the formation of regional laboratories, strain certification, data collection, online reporting, and product development.
For more information please visit: www.BudGenius.com
Chief Executive Officer
Investor Information: www.BGMedTech.com
Forward Looking Statements:
This press announcement includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of company’s management and are subject to significant risks and uncertainties. Forward-looking statements that can be identified by such terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management’s expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, competitive factors, and other matters. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.